Incidence and Prevalence of Alzheimer's Disease in Medicare Beneficiaries.

ABSTRACT:

Introduction

The availability of anti-amyloid therapy for mild cognitive impairment (MCI) due to Alzheimer's disease and mild Alzheimer's dementia (AD) has underscored the need for realistic estimates of the population with AD/MCI within the healthcare system to assure adequate preparedness. We hypothesize that administrative databases can provide real-world epidemiologic estimates reflecting the population with diagnosed (known) MCI and AD. This study was conducted to estimate diagnostic incidence and prevalence of AD and all-cause MCI among the Medicare fee-for-service (FFS) and Medicare Advantage (MA) beneficiaries in the United States.

Methods

This was a retrospective analysis of Medicare beneficiaries (aged 65 and older) with identified diagnoses of AD/MCI based on ≥ 2

SUBMITTER: Zhang H 

PROVIDER: S-EPMC11762046 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature